Celltrion
068270.KS
#881
Rank
ยฃ20.96 B
Marketcap
ยฃ91.41
Share price
3.14%
Change (1 day)
-4.52%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2026 (TTM): ยฃ1.90

According to Celltrion 's latest financial reports the company's current EPS (TTM) is ยฃ1.90. In 2025 the company made an earnings per share (EPS) of ยฃ2.32 an increase over its 2024 EPS that were of ยฃ0.88.

EPS history for Celltrion from 2007 to 2026

Annual EPS

Year EPS Change
2026 (TTM)ยฃ1.90-18.27%
2025ยฃ2.32163.66%
2024ยฃ0.88-53.73%
2023ยฃ1.90-2.08%
2022ยฃ1.94-11.72%
2021ยฃ2.202.03%
2020ยฃ2.1682.8%
2019ยฃ1.1818.31%
2018ยฃ1.00-36.33%
2017ยฃ1.57161.25%
2016ยฃ0.602.86%
2015ยฃ0.5817.84%
2014ยฃ0.495.87%
2013ยฃ0.47-70.85%
2012ยฃ1.60134.09%
2011ยฃ0.6843.59%
2010ยฃ0.4874.49%
2009ยฃ0.27317.8%
2008ยฃ0.06542-71.7%
2007ยฃ0.23